|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/39 | |||
| A61P 35/00 | |||
| A61K 38/19 |
| (11) | Number of the document | 2419126 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10715632.5 |
| Date of filing the European patent application | 2010-04-16 | |
| (97) | Date of publication of the European application | 2012-02-22 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/031460 |
| Date | 2010-04-16 |
| (87) | Number | WO 2010/121180 |
| Date | 2010-10-21 |
| (30) | Number | Date | Country code |
| 170530 P | 2009-04-17 | US |
| (72) |
HODGE, James, US
SCHLOM, Jeffrey, US
FRANZUSOFF, Alex, US
|
| (73) |
Globeimmune, Inc.,
1450 Infinite Drive, Louisville, CO 80027,
US
The United States Of America,As Represented By The Secretary, Department Of Health & Human Services, Office Of Technology Transfer 6011 Executive Boulevard, Suite 325, Rockville, MD 20852-3804, US |
| (54) | COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS |
| COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS |